Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

MLA

Ghebremariam, Yohannes T., et al. “Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine.” Circulation, vol. 128, no. 8, Aug. 2013, pp. 845–53. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.113.003602.

APA

Ghebremariam, Y. T., Lependu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., Leiper, J., & Cooke, J. P. (2013). Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation, 128(8), 845–853. https://doi.org/10.1161/CIRCULATIONAHA.113.003602

Chicago

Ghebremariam, Yohannes T, Paea Lependu, Jerry C Lee, Daniel A Erlanson, Anna Slaviero, Nigam H Shah, James Leiper, and John P Cooke. 2013. “Unexpected Effect of Proton Pump Inhibitors: Elevation of the Cardiovascular Risk Factor Asymmetric Dimethylarginine.” Circulation 128 (8): 845–53. doi:10.1161/CIRCULATIONAHA.113.003602.